Article

bizjournals.com on 2015-08-06 15:50

Brisbane peanut allergy biotech raises $160M in upsized IPO

Related news

Solar installer, peanut allergy biotech IPOs on tap in Bay Area this week bizjournals.com
Silicon Valley , Nevada , Reno , San Francisco Bay Area
FPeanut allergy drug succeeds in clinical trial ft.com
Switzerland , France , New York
Peanut allergy treatment succeeds in study LA Times
Pacific Ocean , Europe , Brisbane , California
Bay Area allergy-fighting biotech stakes out manufacturing in Florida bizjournals.com
California , Clearwater , Silicon Valley
ACorrection: Peanut Allergy Treatment story apnewsarchive.com
Europe , Dallas
Aduro Biotech hits 'unicorn' exit with upsized $119M IPO bizjournals.com
Silicon Valley , San Francisco Bay Area
Upsized and target-topping Bay Area biotech IPO scores $252M bizjournals.com
San Francisco Bay Area
Explosive Bay Area biotech raises $500M in upsized IPO bizjournals.com
San Francisco Bay Area
Peanut-allergy trial holds hope for kids nwaonline.com
Dallas , New England , Little Rock , Arkansas
New Peanut Allergy Drug Shows ‘Lifesaving’ Potential The New York Times
Seattle , Ocala
New peanut-allergy drug shows ‘lifesaving’ potential Seattle Times
Florida , Ocala , Seattle
TFDA-Approval of Palforzia for Peanut Allergy therip.com
Maryland , San Diego , New York , Mount Sinai
Nestlé Moves Further Into Health, Buying Peanut-Allergy Treatment Maker wsj.com
Brisbane
MAimmune Therapeutics stock rallies after FDA approves peanut-allergy drug marketwatch.com
Brisbane
FDA panel recommends approving first peanut allergy treatment The Day